Neurotechnology Research Specialist
Nia Therapeutics
Summary
Nia Therapeutics is developing brain stimulation devices to restore memory function after brain injury and degenerative disease. Our team includes leaders in the fields of engineering, neuroscience, and neurosurgery, and our technology has the potential to revolutionize the treatment of patients with memory loss. In March 2026 our Smart Neurostimulation System (SNS), a wireless, 60-channel, AI-enabled neurostimulation platform, received FDA Breakthrough Device designation, and we are preparing for our first in-human studies.
Job description
We are seeking a highly motivated Research Specialist to join our growing engineering team in Allston, MA. In this role, you will be responsible for a wide variety of tasks, supporting engineering work, device testing, pre-clinical testing, and planning our first-in-human studies using the SNS. You will report to the CEO and to other members of the leadership team when assigned to specific projects.
This in-person position is based at our offices in Allston, MA and requires periodic travel to our Philadelphia office and to our contract manufacturer sites. Must be eligible to work in the US.
Responsibilities
- Build device prototypes at the bench
- Assist with bench testing, pre-clinical testing, and quality engineering
- Assist with planning and executing our upcoming first-in-human studies
- Conduct patient testing and interviews, and engage with patient advocacy groups
Requirements
- Bachelor’s degree in engineering, physics, neuroscience, or cognitive science
- Research experience working with humans or animals in studies that measure and analyze behavioral data
- Clear mission alignment with a team working to develop therapies to treat memory loss
- Quantitative coursework in mathematics and statistics beyond the calculus level
- Excellent organizational, communication, and teamwork abilities
Benefits
- Cash compensation
- Stock options
- Paid time off
- Health insurance
Company overview
Nia Therapeutics is a pioneering medical technology company developing an AI-guided neurostimulation system for the treatment of memory loss. Founded in 2018 and headquartered in Boston, Massachusetts, the company emerged from groundbreaking research funded by the Department of Defense through the DARPA Restoring Active Memory (RAM) project. Nia's core technology is a closed-loop brain-computer interface platform that utilizes artificial intelligence to personalize therapy based on each patient's unique brain activity patterns. The company's Smart Neurostimulation System (SNS) includes an implantable neurostimulator, wearable earpiece, and cloud-based software that work together to interpret complex brain activity related to memory function and provide targeted stimulation. Nia's first clinical target is memory loss due to traumatic brain injury, affecting over 27 million Americans, with plans to expand into mild cognitive impairment and Alzheimer's disease markets. The company has raised significant funding, including a $22 million seed round, and is developing a Class III medical device targeting FDA Premarket Approval. Nia represents a convergence of neuroscience, artificial intelligence, and medical device technology to address one of healthcare's most significant unmet needs.